BioPharma News
MiddleBrook Pharmaceuticals, Inc. Plans Massive Layoffs, CEO Resigns Pfizer Inc. Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer Pfizer Inc. Says Sutent Breast Cancer Trials Fail Sanofi-Aventis K.K. And Bristol-Myers Squibb Company Announce Important Updates to PLAVIX U.S. Prescribing Information; FDA Announces New Boxed Warning on Plavix Roche Holding AG, Genentech (South SF)'s Avastin Fails in Prostate Cancer Study Platelet-Rich Fibrin Matrix Shows No Impact On Clinical Outcomes, Study At American Academy of Orthopaedic Surgeons Conference Finds Women On Pill 'May Live Longer', Aberdeen University Study AVEO Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering FDA Approves Eisai Inc.'s Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) Breast Cancer Drug Fulvestrant Appears More Effective in the Presence of CK8 and CK18, Indiana University Study Novel Stroke Treatment Passes Safety Stage of Clinical Trial At University of California, Irvine Study Movement Disorder Symptoms Are Lessened by an Antibiotic, University of Alabama at Birmingham Study University of Essex Scientists Make Important Discovery in Gene Regulation Ipsen Grants Obesity Treatment Licence; will Receive up to $80 Million Genetix Pharmaceuticals, Inc. Secures $35 Million in Series B Funding Arena Pharmaceuticals, Inc. will Launch Lorcaserin with Partner or Alone University of Iowa Research Points to Way to Improve Heart Treatment FDA Approves Watson Pharmaceuticals, Inc.'s TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer TaiGen Biotechnology Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints Progenics Pharmaceuticals, Inc. to Advance Oral Methylnaltrexone into Late Stage Clinical Development Calcium May Help You Live Longer, Karolinska Institute Study Tumor Surgery Impairs Sexuality, Study in Ligand Pharmaceuticals Inc. Announces Approval for GlaxoSmithKline's Revolade(R) in Europe Azur Pharma Inc. to Acquire Elan Corporation PLC's Painkiller Prialt AstraZeneca PLC Boosts Generic Exposure with Torrent Pharmaceuticals Ltd. Deal Despite Law, Drug Safety Still A Concern At FDA Portola Pharmaceuticals, Inc.'s Announces CEO, M.D. to Retire Patient Safety Reporting and Drug Label Accuracy Missing Vital Information, Expert From Memorial Sloan-Kettering Cancer Center Says 200 Manchester Jobs Under Threat in AstraZeneca PLC Cuts Drug-Resistant Lice Respond Better to Ivermectin, Study in The New England Journal of Medicine Local Pharma Can And Should Step Up Outsourcing Play Disease Cause Is Pinpointed With Genome, Baylor College of Medicine Study Experimental Drug That Mimics Thryoid Hormone Safely Lowers 'Bad' Cholesterol, Johns Hopkins University School of Medicine Study FDA Rules Out Thigh Fracture Link with Bisphosphonate, Including Medications such as Merck & Co., Inc.'s Fosamax Hormone Thought to Slow Aging Associated With Increased Risk of Cancer Death, University of California, San Diego (UCSD) Study Clark Johnson Appointed Neurologix, Inc. President and CEO BioSante Pharmaceuticals, Inc. Says Leukemia Vaccine Shows Promise in Study Senetek PLC Embarks on New Strategic Direction; Company Completes $3.0 Million Financing; CEO and CFO Terminated in Connection with Financing Discovery of 'Fat' Taste Could Hold the Key to Reducing Obesity, Deakin University Study Basilea Pharmaceutica: Johnson & Johnson Seeks Europe Rehearing on Skin Drug Turning Tables On Prostate Cancer's Drug Resistance, University of California, San Diego (UCSD) Study OXiGENE Announces $7.5 Million Financing Beijing to Build Asia's Largest Pharmaceutical Base Seaweed Extract May Hold Promise for Non-Hodgkin's Lymphoma Treatment, The Hashemite University Study UCB Group: Newly-Published Study Reinforces Role of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) as an Add-on Treatment that Significantly Reduces Partial-onset Seizures in Adults with Epilepsy University of Pittsburgh Medical Center Gets New Partners in Plan for Vaccine Factory Merck & Co., Inc.'s Stromectol Wipes Out Hard-to-Treat Lice, Study Finds Abbott Laboratories to Buy Facet Biotech for $722 Million Amylin Pharmaceuticals, Inc., Eli Lilly and Company Diabetes Drug Faces Crucial FDA Decision Novartis Corporation Takes Option on TRANSGENE Cancer Vaccine; Gets $10 Million, Milestones Could Reach $950 Million Lacosamide Validated as Promising Therapy for Uncontrolled Partial-Onset Seizures, Barrow Neurological Institute, St. Joseph's Hospital, And Thomas Jefferson University Study FDA Advisory Committee Recommends Approval of InterMune, Inc.'s Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis Exelixis, Inc. Announces Restructuring; Reduces Workforce by Approximately 40%, or 270 Employees Skin Transplant Offers New Hope to Vitiligo Patients, Henry Ford Hospital Study Cytokinetics, Inc.'s Lou Gehrig's Drug Gets Orphan Status University of California, San Diego (UCSD) Study Shows Potential for Using Algae to Produce Human Therapeutic Proteins Merck & Co., Inc.'s Fosamax: Is Long Term Use of Bone Strengthening Drug Linked to Fractures? Watson Pharmaceuticals, Inc., Takeda Pharmaceutical Co. Ltd. Resolve Actos Patent Litigation University of Missouri Researcher Presents Risk-free Treatment for Low Female Sexual Desire Bristol-Myers Squibb Company CEO's 2009 Compensation Down 22% Affymax, Inc. Receives $5 Million Milestone Payment from Takeda Pharmaceutical Co. Ltd. on Initiation of Phase 3 Clinical Trials for Hematide in Japan University of Southern California Research Finds Shortcomings in Comparative Effectiveness Drug Research Neuropharm Group plc to Mull Voluntary Liquidation to Return Cash Oculus Innovative Sciences, Inc. Receives First FDA Clearance for Microcyn(R)-Based HydroGel for Dermatology Market Transplant Drug Preserves Kidneys, Avoids Toxicity, Emory University Studies Suggest Allergan Inc.'s BOTOX(R) (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults Osteoporosis Drug Improves Healing After Rotator Cuff Surgery, Hospital for Special Surgery Study Virus To Treat Prostate Cancer, Study Obesity And Type 2 Diabetes Market Closely Linked But Vastly Different In Outlook Ark Therapeutics Pulls Drug Application, Weighs Sale of Company Back Researchers, Not Research, Say U.K. Science Advisers Trading Halted Today in InterMune, Inc. Common Stock; FDA Advisory Committee Reviewing Pirfenidone Data in Idiopathic Pulmonary Fibrosis New Ways to Disarm Deadly South American Hemorrhagic Fever Viruses, Howard Hughes Medical Institute Study ECG Screening Found Cost-Effective In Kids With ADHD Considered For Stimulant Drugs, National Institutes of Health (NIH) Study Cheers! A Drink a Day May Keep the Pounds Away, Brigham and Women's Hospital Study University of Copenhagen Scientists Find Why "Sunshine" Vitamin D Is Crucial AIDS Virus Can Hide In Bone Marrow, University of Michigan Study AutoImmune, Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution BT PHARMA Secures USD 17.7 Million in Capital Funding and Changes its Name to Genticel OSI Pharmaceuticals, Inc. Bid Likely to Rise as Astellas Pharma Inc. Seeks Cancer Sales ISTA Pharmaceuticals, Inc. Receives PDUFA Action Date of October 16, 2010 for FDA Review of Once-Daily XiDay(TM) Sanofi-Aventis (France), Merck & Co., Inc. to Create Animal Health Leader; to Pay $250 Million Plus $750 Million Matrixx Initiatives, Inc. Says FDA Declines to Withdraw Warning Letter New Method to Grow Arteries Could Lead to 'Biological Bypass' for Heart Disease, Yale University School Of Medicine Study Bleeding Alert Sounded for Stroke Drugs, Rush University Medical Center Study INSYS Therapeutics Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray XenoPort, Inc. Restructures to Focus on Key Programs; Includes An Overall Reduction of 50% of s Workforce AstraZeneca PLC's Recentin Fails Phase 3 Trial, Hurts Shares ExonHit Therapeutics Inc. and bioMerieux, Inc. Decide Not to Pursue Colon Cancer Program Gene Site Discovered for a Children's Food Allergy, Study Most Early-Stage Breast Cancer Patients May Not Need Radiation After Mastectomy, University of Texas MD Anderson Cancer Center Study Repeated Anesthesia Can Affect Childrens Ability To Learn, Study Eli Lilly and Company to Acquire European Rights to Pfizer Animal Health Assets Roche Holding AG, Biogen Idec, Inc. (Massachusetts) Suspends Arthritis Treatment Ocrelizumab After Deaths NicOx SA Announces FDA Advisory Committee to Discuss Naproxcinod on May 12; PDUFA Date Set for July 24, 2010 Genta Incorporated Announces $25 Million Financing New Basis for Drug Development: Structure Determination of Biomolecules in Their Natural Environment, Helmholtz Zentrum Munchen Study Nektar Therapeutics Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Cancer Snake Venom Charms Science World, Study in Cell Therapeutics, Inc. Says FDA OKs Manufacturing Facility Isis Pharmaceuticals, Inc. Earns $6 Million Milestone Payment From Bristol-Myers Squibb Company for BMS-PCSK9Rx EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by to Advance Epanova(TM), a Prescription Omega 3 Therapy Two-Faced Testosterone Can Make You Nasty Or Nice, Stanford University Study Pharma Layoff Stats Show the Glory Days of Drugs Won't Be Coming Back Dutch Government Wants To Sell Flu Vaccines Back To Novartis AG And GlaxoSmithKline Trial Launched to Test New Treatment for Pre-Invasive Breast Cancer, George Mason University Study Dietary Supplements Discouraged For Prostate Cancer Patients, Study New Strategy Develops Two Prototype Drugs Against Cancer, Retinal Diseases, University of Texas MD Anderson Cancer Center Study Life Sciences Gets Push From Missouri Policymakers In Case You Missed It: /A>'s EPI / NPAM 2010 FDA to Increase Criminal Prosecutions of Execs The Pharmaceutical R&D Model is Broken. Here's How to Fix It Effect of InterMune, Inc.'s Lung Drug, Pirfenidone Unclear; Shares Soar Despite FDA Concerns Big Pharma Struggles To Benefit From Increased CVD Drug Usage CSL Behring Receives FDA Approval of HizentraTM, First 20 Percent Subcutaneous Immunoglobulin Therapy Hope For An Alzheimer's Breakthrough Remains Despite Pfizer Inc.'s Dimebon's Failure Hope For An Alzheimer's Breakthrough Remains Despite Pfizer Inc.'s Dimebon's Failure Putting Gene Duo To Work For Parkinson's, University of Sheffield Study Scientists Identify New Drugs for Treating PTSD, University of Texas Study Experimental Vaccine Protects Monkeys Against Mosquito-Borne Chikungunya Virus, University of Texas Study Pfizer Inc. Cholesterol Flops Cleared Path for Resverlogix Corporation Court Backs Five-Year Exclusivity for Shire plc's ADHD Drug Vyvanse Merck & Co., Inc. Sues Teva Pharmaceutical Industries Limited to Block Generic Vytorin Astellas Pharma Inc. Needs to Raise OSI Pharmaceuticals, Inc. Bid by 15%, OrbiMed Says
Jobs by Indeed
BioMaterial News
